Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03255213 · ClinicalTrials.gov registry record · NA
Lingual Muscle Training in Late-Onset Pompe Disease (LOPD)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03255213: Completed NA study, sponsored by Duke University.
NCT03255213 is a NA study that has completed, run by Duke University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03255213, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study is being done to test the effects of Lingual Muscle Therapy (LMT) in patients with Late-Onset Pompe Disease (LOPD) who have tongue weakness. The results of this study will help design future research studies about LMT in LOPD.
Primary Outcome
Safety measured by pain rating scale
Interventions
- OTHER Lingual Muscle Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-03-21 |
| Est. Completion | 2020-04-23 |
| Phase | NA |
What the finished NCT03255213 record still lists
NCT03255213 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Lingual Muscle Training is the first listed.
NCT03255213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03255213 about?
NCT03255213 is a clinical study titled "Lingual Muscle Training in Late-Onset Pompe Disease (LOPD)". This study is being done to test the effects of Lingual Muscle Therapy (LMT) in patients with Late-Onset Pompe Disease (LOPD) who have tongue weakness. The results of this study will help design future research studies about LMT in LOPD.
What is the current status of trial NCT03255213?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-03-21. Estimated completion is 2020-04-23.
What interventions are being tested in trial NCT03255213?
The interventions under investigation include: Lingual Muscle Training (OTHER).
Who is sponsoring clinical trial NCT03255213?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03255213's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI